CEO of Pfizer to step down

MG News | October 01, 2018 at 05:45 PM GMT+05:00

0:00

October 1, 2018: Us pharmaceutical giant Pfizer has announced that its operating chief Albert Bourla will be the next Chief Executive Officer from January 1 2019, replacing Ian Read who held the top post at the drugmaker for the last eight years.

Read will take over the role of executive chairman, the company said in a statement.

"It's been an honor to serve as Pfizer's CEO for the past eight years. However, now is the right time for a leadership change, and Albert is the right person to guide Pfizer through the coming era," Ian was quoted as saying.

Under Read's tenure, Pfizer won 30 approvals from the U.S. health regulator as well as weathered patent expiration on a few of its blockbusters, including cholesterol drug, Lipitor.

APP

Related News

Name	Price/Vol	%Chg/NChg
KSE100	161,935.19 239.78M	0.80% 1277.69
ALLSHR	97,989.64 672.11M	0.80% 780.92
KSE30	49,083.13 162.29M	0.73% 357.18
KMI30	231,590.57 121.07M	0.80% 1835.48
KMIALLSHR	63,730.38 301.36M	0.65% 414.39
BKTi	44,511.26 43.79M	1.00% 442.70
OGTi	31,229.10 21.20M	1.42% 438.44

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	95,445.00	100,495.00 94,580.00	-2680.00 -2.73%
BRENT CRUDE	64.27	64.87 63.36	1.26 2.00%
RICHARDS BAY COAL MONTHLY	85.00	85.00 85.00	0.05 0.06%
ROTTERDAM COAL MONTHLY	96.45	96.45 95.75	1.20 1.26%
USD RBD PALM OLEIN	1,082.50	1,082.50 1,082.50	0.00 0.00%
CRUDE OIL - WTI	59.94	60.65 58.71	1.25 2.13%
SUGAR #11 WORLD	14.85	15.05 14.35	0.41 2.84%